Global Brain Aneurysm Treatment Market Expected to Grow at a CAGR of 5.4% During the Forecast Period with Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2023

Brain aneurysm is an abnormal bulge in the blood vessels of the brain that can go on to cause severe health-based issues and           possible even death. It causes the inner muscular layer of the blood vessel wall to weaken. After a prolonged period of time, the blood flow within the artery keeps pushing the thin wall portion and eventually ends-up rupturing it. The bleeding caused due to the ruptured brain artery is known as subarachnoid hemorrhage (SAH).

Ask for free sample@ https://www.marketresearchfuture.com/sample_request/4561

The hemorrhage is so severe that it can lead to stroke, coma, or even death. Various factors contribute to its occurrence, including injury or trauma, cigarette smoking, blood infections, and others. Individuals suffering from this condition of brain aneurysm can be diagnoses through multiple means or techniques, including cerebral angiogram, Computed Tomography (CT) scan, Magnetic Resonance Angiography (MRA), Computed Tomography Angiogram (CTA) scan, and many others.

The global brain aneurysm treatment market is expected to grow at a compound annual rate of 5.4% during the forecast period between 2017 and 2023.

Market Research Future (MRFR) asserts in its report that the global market is influenced by various key factors. This includes, the increasing and widespread prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid advancements in surgical techniques, and increasing funding by the government and related bodies in the healthcare sector. Also, the presence of brain aneurysm in the family is another key driver of the market.

However, issues like high management cost of aneurysmal subarachnoid hemorrhage and unknown symptoms of unruptured brain aneurysm can hamper the overall growth of the market.

Competitive Landscape

The global brain aneurysm treatment market includes a number of key players, including Sophysa Ltd., Codman & Shurtleff, Inc., Medtronic Plc., Orsan Medical Technologies, Head Sense Medical, InfraScan, Inc., MicroPort Scientific Corporation, Raumedic AG, HaiWeiKang, Johnson & Johnson, Spiegelberg GmbH, Vittamed, and others.

April 2^nd, 2019, an all-new and approved treatment device to fight against brain aneurysms was available in Toledo. With an estimated 6 million people in the United States suffering from unruptured brain aneurysms, this development will be of great advantage.

April 16^th, 2019, Stryker, a medical technology company, announced the introduction of the next generation Surpass Evolve Flow Diverter to treat and cure brain aneurysms.